MADISON – Company working on a prostate cancer vaccine receives funding

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin.

Madison Vaccines Incorporated said Monday the company has closed on $8 million in financing to move forward with its therapies for prostate cancer.

 
MVI is working on two vaccines to combat prostate cancer, one of which is in Phase 2 clinical trials. The technology was developed in the lab of UW-Madison medical school professor Douglas McNeel.

Read more.

What's New

BizPeople

Sponsored Content

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.